2-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 5g

trans-4-(Hydroxymethyl)cyclohexanecarboxylic Acid>98.0%(GC)(T)5g

2�-Bromo-2-hydroxyacetophenone, 95%, 5g

4-Amino-3-bromo-5-methylbenzoic acid, 95.0%, 5g

3-Chloro-5-fluorophenylacetylene, 1g

(Z)-N-(1-(4-Bromophenyl)-1-chloro-3-oxo-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, 95%, 100mg

4-(5-Methyl-1h-pyrazol-1-yl)benzoic acid, 95+%, 250mg

4-Chloro-5-hydroxypyridazin-3(2H)-one, 95.0%, 5g

1,3-dithiolane-2-carboxylic acid, 95.0%, 500mg

1'-Boc-5-Bromo-1,2-dihydro-2-oxo-spiro[3H-indole-3,4'-piperidine], 95.0%, 1g

Di-tert-butyl 1,4-dioxo-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-2,5(1H,4H)-dicarboxylate, 95%, 25mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(o-tolyl)propanoic acid, 95.0%, 10g

Lámina de cobre 99,95% 0,07 x 150 x 150 mm 1 ud.